Trial · NCT02499679
Results by group30
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 30
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
Percentage of Participants With Reclassification of CAD Management, Assessed as the Therapeutic Recommendations Made Based on Review of Coronary CTA Alone Versus CTA + FFRCT, When Available, by a Central Integration Core Laboratory. | Reclassification Rate by Core Lab | 66.9 | 95% Confidence Interval 64.8 to 67.6 | percentage of participants | |
| Percentage of Participants With Reclassification Between Investigator Management Plan Based on cCTA Alone Compared to Actual Clinical Management | Reclassification Rate by Investigator Management Plan | 63.5 | 95% Confidence Interval 62.0 to 65 | percentage of participants | |
| Percentage of Participants With Invasive Catheterization Without Obstructive Disease | ICA Patients With FFRCT >0.80 | 43.8 | percentage of participants | ||
| Percentage of Participants With Invasive Catheterization Without Obstructive Disease | ICA Patients With FFRCT ≤0.80 | 14.4 | percentage of participants | ||
| Percentage of Major Adverse Coronary Events (MACE) at 90 Days | MACE Events Within 90 Days Subject Whose FFRCT Was >0.80 | 0 | Participants | ||
| Percentage of Major Adverse Coronary Events (MACE) at 90 Days | MACE Events Within 90 Days. Patients With at Least One FFRCT Value ≤ 0.80 | 19 | Participants | ||
| Percentage of Individual Components of MACE at 90 Days | Patients With cCTA and FFRCT > 0.80 | MI | 0 | Participants | |
| Percentage of Individual Components of MACE at 90 Days | Patients With cCTA and at Least One FFRCT Value ≤ 0.80 | MI | 4 | Participants | |
| Percentage of Individual Components of MACE at 90 Days | Patients With cCTA and FFRCT > 0.80 | Urgent unplanned hospitazation for ACS and urgent revascularization. | 0 | Participants | |
| Percentage of Individual Components of MACE at 90 Days | Patients With cCTA and at Least One FFRCT Value ≤ 0.80 | Urgent unplanned hospitazation for ACS and urgent revascularization. | 5 | Participants | |
| Percentage of Individual Components of MACE at 90 Days | Patients With cCTA and FFRCT > 0.80 | Death | 0 | Participants | |
| Percentage of Individual Components of MACE at 90 Days | Patients With cCTA and at Least One FFRCT Value ≤ 0.80 | Death | 10 | Participants | |
| Cumulative Radiation Exposure From cCTA MilliSievert (mSv) | All Patients Diagnosed With CAD by cCTA Undergoing cCTA and FFRCT Analysis | 10.0 | Standard Deviation 9.1 | mSv | |
| Resource Utilization at 90 Days. Site-determined Post FFRCT Treatment Plan | Site-determined Post-FFRCT Treatment Plan - Revascularization | Medical Therapy | 504 | Participants | |
| Resource Utilization at 90 Days. Site-determined Post FFRCT Treatment Plan | Site-determined Post-FFRCT Treatment Plan - Medications | Medical Therapy | 2545 | Participants | |
| Resource Utilization at 90 Days. Site-determined Post FFRCT Treatment Plan | Site-determined Post-FFRCT Treatment Plan - Further Diagnostics | Medical Therapy | 92 | Participants | |
| Resource Utilization at 90 Days. Site-determined Post FFRCT Treatment Plan | Site-determined Post-FFRCT Treatment Plan - Revascularization | PCI | 799 | Participants | |
| Resource Utilization at 90 Days. Site-determined Post FFRCT Treatment Plan | Site-determined Post-FFRCT Treatment Plan - Medications | PCI | 115 | Participants | |
| Resource Utilization at 90 Days. Site-determined Post FFRCT Treatment Plan | Site-determined Post-FFRCT Treatment Plan - Further Diagnostics | PCI | 25 | Participants | |
| Resource Utilization at 90 Days. Site-determined Post FFRCT Treatment Plan | Site-determined Post-FFRCT Treatment Plan - Revascularization | CABG | 115 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02499679/results